Grantham, Mayo, Van Otterloo & Co (GMO)’s Halliburton HAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
– Sell
-170,100
Closed -$7.26M – 591
2017
Q2
$7.26M Buy
170,100
+15,500
+10% +$712K 0.04% 206
2017
Q1
$7.61M Buy
154,600
+46,700
+43% +$2.51M 0.04% 202
2016
Q4
$5.84M Buy
+107,900
New +$5.38M 0.03% 233

Other funds holding HAL

Grantham, Mayo, Van Otterloo & Co (GMO)'s HAL Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Halliburton (HAL) stake by 11% in Q2 2026, buying an estimated $1.14M and bringing the position to 282,338 shares worth $9.59M. The position accounts for 0.02% of the portfolio, ranked #260.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HAL in Q2 2013 and has held it in 12 quarters since. The position peaked at $9.87M in Q1 2026. 1,207 funds tracked by Wall St. Rank hold HAL as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 282,338 shares of Halliburton worth $9.59M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 29,107 Halliburton shares in Q2 2026, an estimated $1.14M.
  • Halliburton made up 0.02% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #260 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Halliburton in Q2 2013 and has held it in 12 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Halliburton position peaked at $9.87M in Q1 2026.
  • 1,207 funds tracked by Wall St. Rank held Halliburton as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.